A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B

Chronic Hepatitis ◽

Hepatitis B ◽

Adefovir Dipivoxil ◽

Controlled Trial ◽

Pegylated Interferon ◽

Hepatitis B E Antigen ◽

Randomized Controlled ◽

Interferon Α2a ◽

A randomized controlled trial of pegylated interferon-alpha with tenofovir disoproxil fumarate for hepatitis B e antigen-negative chronic hepatitis B: A 48-week follow-up study

Journal of Infection and Chemotherapy ◽

10.1016/j.jiac.2020.07.005 ◽

2020 ◽

Vol 26 (12) ◽

pp. 1265-1271

Author(s):

Mansour Bahardoust ◽

Marjan Mokhtare ◽

Mitra Barati ◽

Zahra Bagheri-Hosseinabadi ◽

Arman Karimi Behnagh ◽

...

Keyword(s):

Hepatitis B ◽

Controlled Trial ◽

Pegylated Interferon ◽

Hepatitis B E Antigen ◽

Pegylated Interferon Alpha ◽

Follow Up Study ◽

Randomized Controlled ◽

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

Clinical and Molecular Hepatology ◽

10.3350/cmh.2016.0040 ◽

2017 ◽

Vol 23 (4) ◽

pp. 331-339 ◽

Cited By ~ 8

Author(s):

Kwan Sik Lee ◽

Young-Oh Kweon ◽

Soon-Ho Um ◽

Byung-Ho Kim ◽

Young Suk Lim ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Efficacy And Safety ◽

Hepatitis B E Antigen ◽

Korean Patients ◽

Randomized Controlled ◽

A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B

Hepatology ◽

10.1053/jhep.1996.v24.pm0008855175 ◽

1996 ◽

Vol 24 (4) ◽

pp. 774-777 ◽

Cited By ~ 4

Author(s):

P Andreone

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Controlled Trial ◽

Interferon Alfa ◽

Hepatitis B E Antigen ◽

Randomized Controlled ◽

B Virus ◽

Positive Chronic Hepatitis ◽

Antigen Antibody

Faculty of 1000 evaluation for A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717954582.793470405 ◽

2013 ◽

Author(s):

Glenn Tillotson

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Randomized Controlled ◽

A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone

Annals of Internal Medicine ◽

10.7326/0003-4819-142-4-200502150-00006 ◽

2005 ◽

Vol 142 (4) ◽

pp. 240 ◽

Cited By ~ 195

Author(s):

Henry Lik-Yuen Chan ◽

Nancy Wai-Yee Leung ◽

Alex Yui Hui ◽

Vincent Wai-Sun Wong ◽

Choong-Tsek Liew ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Combination Therapy ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Pegylated Interferon ◽

Randomized Controlled ◽

Interferon Α2b

A randomized controlled trial of thymosin-?1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody?and hepatitis B virus DNA?positive chronic hepatitis B

Hepatology ◽

10.1002/hep.510240404 ◽

1996 ◽

Vol 24 (4) ◽

pp. 774-777 ◽

Cited By ~ 1

Author(s):

P Andreone ◽

C Cursaro ◽

A Gramenzi ◽

C Zavaglia ◽

I Rezakovic ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Controlled Trial ◽

Interferon Alfa ◽

Hepatitis B E Antigen ◽

Randomized Controlled ◽

B Virus ◽

Positive Chronic Hepatitis ◽

Antigen Antibody

Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial

Journal of Viral Hepatitis ◽

10.1111/jvh.12313 ◽

2014 ◽

Vol 22 (2) ◽

pp. 85-93 ◽

Cited By ~ 20

Author(s):

J. L. Hou ◽

Z. L. Gao ◽

Q. Xie ◽

J. M. Zhang ◽

J. F. Sheng ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Adefovir Dipivoxil ◽

Controlled Trial ◽

Chinese Patients ◽

Randomized Controlled

A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp2281 ◽

2012 ◽

Vol 18 (1) ◽

pp. 57-64 ◽

Cited By ~ 16

Author(s):

Paola Piccolo ◽

Ilaria Lenci ◽

Daniele di Paolo ◽

Luigi Demelia ◽

Orazio Sorbello ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Randomized Controlled ◽

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

Hepatology ◽

10.1002/hep.510260634 ◽

1997 ◽

Vol 26 (6) ◽

pp. 1621-1625 ◽

Cited By ~ 127

Author(s):

P Lampertico ◽

E Del Ninno ◽

A Manzin ◽

M F Donato ◽

M G Rumi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Interferon Alfa ◽

Hepatitis B E Antigen ◽

Randomized Controlled ◽

B Virus

Interferon alfa therapy for chronic hepatitis B in children: A multinational randomized controlled trial☆

Gastroenterology ◽

10.1016/s0016-5085(98)70318-x ◽

1998 ◽

Vol 114 (5) ◽

pp. 988-995 ◽

Cited By ~ 172

Author(s):

Etienne Marc Sokal ◽

Hari S. Conjeevaram ◽

Eve A. Roberts ◽

Fernando Alvarez ◽

Elana M. Bern ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Controlled Trial ◽

Interferon Alfa ◽

Randomized Controlled